Now let me finalize by comparing CMT against the Round 2 anchors:

**BoPITO (7.00):** Uses Boltzmann generators as priors for transfer operators. Evaluated on only 1D Prinz potential and alanine dipeptide. Reviewers note "limited experiments" and "lack of comparison with other ML-based approaches." CMT is clearly stronger empirically (4 molecular systems up to d=219, FAB and TA-BG baselines, ablation study) with comparably strong theory.

**GFlowNets (7.33):** Different domain (discrete/structured sampling). Strong theory + empirical validation but in a completely different problem space. Hard to compare directly.

CMT sits above BoPITO on empirical completeness but has a factual inaccuracy (claiming Ram TV superiority on all systems when TA-BG wins on ELIL) and an oversold abstract claim. These are fixable narrative issues, not methodological flaws. The core contribution — the constrained optimization framework with analytical solutions and the ablation-validated dual-constraint design — is strong.

**Final score: 7.0. Decision: Accept.**

---

## Summary
This paper introduces Constrained Mass Transport (CMT), a variational framework for learning Boltzmann generators that constructs intermediate densities along an annealing path by solving constrained optimization problems with both a trust-region (KL) bound and an entropy-decay bound between successive steps. The theory yields closed-form intermediate densities (Propositions 2.1–2.3) that map onto geometric, tempered, and geometric-tempered annealing paths (Theorem 2.4). The method is instantiated with normalizing flows and evaluated on four molecular benchmarks including the newly introduced ELIL tetrapeptide (d=219), where it consistently outperforms FAB and TA-BG on most metrics.

## Strengths
- **Clean theoretical framework with closed-form solutions:** Propositions 2.1–2.3 provide analytical expressions for the optimal intermediate densities under trust-region, entropy, and combined constraints. Theorem 2.4 connects these to interpretable annealing paths (geometric, tempered, geometric-tempered) with monotonic schedule parameters. This principled derivation distinguishes CMT from heuristic annealing schedules.
- **Convincing ablation study demonstrating necessity of both constraints (Figures 2, 3):** On alanine hexapeptide, removing either constraint produces visible mode collapse in Ramachandran plots and collapses the ESS between successive intermediates. The combined geometric-tempered variant avoids these failure modes, directly validating the paper's central design claim.
- **Strong empirical results with widening gap on harder systems:** CMT achieves the best EUBO and ESS on all four systems at matched or lower target-evaluation budgets. On alanine hexapeptide (d=180), CMT reaches 29.63% ESS vs. 18.22% for TA-BG (1.6×); on ELIL tetrapeptide (d=219), 26.06% vs. 13.75% for TA-BG (1.9×). The performance margin grows with system difficulty.
- **Introduction of ELIL tetrapeptide benchmark (d=219):** A meaningful new stress test for energy-only Boltzmann generator learning that exposes limitations of existing methods (reverse KL collapses to 1.26% ESS, forward KL to 5.85%) and demonstrates CMT's robustness at scale.
- **Well-designed evaluation protocol:** EUBO (mode collapse detection), ESS (importance-sampling efficiency), and Ramachandran TV (physical correctness) provide complementary views of performance, reducing the risk that gains are artifacts of a single metric.

## Weaknesses

### Fatal
None.

### Major
- **Factual inaccuracy in results interpretation (line 237):** The text claims CMT provides "superior mode coverage" on Ram TV "across all systems and metrics." However, Table 1 shows that TA-BG achieves better Ram TV than CMT on the ELIL tetrapeptide (2.54 vs. 3.13 × 10⁻²). The paper should acknowledge this exception and discuss possible reasons (e.g., CMT's entropy constraint may favor broader exploration at the cost of some fidelity in dihedral-angle distributions). This is a clear factual error that undermines trust in the results narrative.

### Minor
- **Abstract's "2.5× higher ESS" claim is not supported against the strongest baseline:** The abstract claims "more than 2.5× higher effective sample size" without qualification. Against TA-BG — the strongest and most directly comparable baseline — the ESS improvement is 1.6× on alanine hexapeptide and 1.9× on ELIL tetrapeptide. The >2.5× factor is only achieved against FAB (3.6× on ELIL) or reverse KL. The main text (line 238) more accurately states "approximately twice the ESS," but the abstract overclaims relative to what the data supports against the leading competitor. The claim should be qualified.
- **TA-BG comparison on ELIL is on unequal footing:** TA-BG had only 2 successful runs on ELIL (vs. 4 for CMT) due to numerical instabilities, as noted in the Table 1 caption. While this could reflect CMT's greater stability, it also means the TA-BG statistics on ELIL have substantially higher uncertainty and the comparison is less reliable than the other benchmarks. The paper is transparent about this but it warrants more discussion when interpreting results on the largest system.
- **Hyperparameter values absent from main evaluation:** The specific values of ε_tr, ε_ent, and the number of annealing steps T̃ for each benchmark are deferred to appendices. While the sensitivity analysis exists (Appendix B), including these values in the main experimental section would help readers assess how much tuning was required. For a method whose core contribution is these constraints, this is a meaningful omission from the main presentation.

### Trivial
- **Notation inconsistency:** The trust-region bound is denoted ε_tr in equations (2) and (9) but ε_u in the surrounding text (line 56) and in equations (3) and (6). This should be unified.
- **EUBO standard errors reported as 0.00:** With only 4 runs, reporting standard errors of exactly 0.00 for most EUBO entries is implausible and likely a rounding artifact. The actual precision should be reported.

## Nice-to-Haves
- Extending the ablation study (Figures 2, 3) to at least one additional system beyond alanine hexapeptide would strengthen the claim that both constraints are generally necessary.
- A sensitivity analysis over ε_tr and ε_ent values on both a small and large system would increase confidence that CMT is robust to these hyperparameter choices.
- The paper could more explicitly discuss the structural property of Proposition 2.2 — that the entropy-constrained optimal intermediate density does not depend on q_i (equation 8), which explains why the entropy constraint alone is unstable and why the trust-region constraint is structurally necessary.
- Including a diffusion-based Boltzmann generator baseline would substantiate the related-work claim (line 176-177) that such methods are "less competitive."

## Removed Points
These points are flagged to be removed, treat them with caution.

- **Harsh Critic's "theory-practice mismatch" claim (reverse KL vs. forward KL):** The critic claims the paper switches from reverse KL in theory to forward KL in practice without addressing it. This is incorrect: the constrained problems (2), (7), (9) minimize D_KL(q || p) (reverse KL to target) to determine what the next intermediate density should be, while the fitting step (13)-(15) uses forward KL D_KL(q_{i+1} || q̂) to fit a parametric approximation to that analytical density. These are two different stages with different objectives. The paper explicitly discusses the forward KL choice for the fitting step (lines 142-144), explaining it encourages mode coverage. No reversal exists.
- **Harsh Critic's concern about Monte Carlo estimator variance in (16):** The paper addresses this by stating the trust-region constraint bounds the importance-weight variance (line 144, referring to Appendix C.3). Not an unaddressed gap.
- **Harsh Critic's demand for Theorem 2.4 monotonicity proof sketch:** The proof is in Appendix A, which is standard. Hard rules require removing criticisms about missing appendix proofs.
- **Harsh Critic's claim that "trust-region constraint does not actually avoid geometric annealing":** The paper is explicit about this — line 28 states the trust-region constraint "results in the geometric annealing path with automatic schedule tuning." The critic is restating what the paper already says.
- **Harsh Critic's claim about "2.5× claim is unverifiable":** This is false — the claim IS verifiable against FAB on ELIL (26.06/7.21 = 3.6×). The real issue is selectivity (not supported against the strongest baseline), which is captured in the Minor weakness above.
- **Harsh Critic's demand for Ramachandran plot for ELIL tetrapeptide:** The paper provides Ramachandran plots via Ram TV metric; the specific visualization format is a nice-to-have, not a weakness.
- **Strength Finder's claim about "superior mode coverage across all metrics":** Conflicts with the verified weakness that TA-BG wins Ram TV on ELIL. Removed as a standalone strength; the evidence is qualified in the weaknesses section.
- **Strength Finder's "consistent empirical superiority across all benchmarks" (unqualified):** Qualified in the review to reflect the Ram TV exception on ELIL.

## Novel Insights
The paper's structural finding that the entropy-constrained optimal intermediate density (Proposition 2.2, equation 8) does not depend on q_i — it "forgets" the previous distribution entirely — is noteworthy and under-emphasized in the paper. This property means the entropy constraint alone cannot produce a coherent transport path because each step would jump directly toward a tempered version of the target with no memory of the path so far. The paper's ablation results implicitly confirm this: the entropy-only variant shows unstable training (Figure 2b). This makes the combination with the trust-region constraint not merely beneficial but structurally necessary, which is a stronger conclusion than the paper currently draws.

## Suggestions
- Correct line 237 to acknowledge that TA-BG achieves better Ram TV on ELIL tetrapeptide and discuss possible reasons for this exception.
- Qualify the abstract's "2.5×" claim by specifying which baseline it refers to, or calibrate it to the strongest comparison (approximately 1.6–1.9× against TA-BG).
- Move ε_tr, ε_ent values and T̃ into the main experimental section (even a compact table would suffice).
- Unify the trust-region bound notation (pick ε_tr or ε_u consistently).
- Report EUBO standard errors with appropriate precision rather than 0.00.

## Calibration Summary

**Round 1 anchors (bracketing):**
- DynamicsDiffusion (3.00): Diffusion for MD trajectories, different problem. CMT is substantially stronger.
- Global Minima (2.60): Global optimization, not comparable.
- CG Potentials (3.00): Coarse-grained modeling, not comparable.
- Phase-aware Training (3.00): Flow-based training schedule, tangentially related. CMT is stronger.
- Neural Sampling from Boltzmann Densities / TUvg5uwdeG (6.40): Most relevant anchor — similar problem, theory-heavy, but only 2D/8D experiments. CMT is clearly stronger empirically.
- Annealing Flow (3.60): CNF for sampling, rejected. CMT is stronger.
- COFlowNet (5.67): GFlowNet constraints, different problem.
- BNEM / ybWOYIuFl6 (6.00): Boltzmann sampler, rejected. Evaluated on toy systems only. CMT is substantially stronger.
- GeoBFN (8.00): Molecular geometry generation, different problem domain.
- FoldFlow (8.00): Protein backbone generation, different problem domain.
- Diffusion Graph Networks (7.60): Fluid simulations, different problem.
- Discrete Walk-Jump Sampling (8.00): Protein discovery, different problem.

**Round 1 bracket: 6.5–8.0**

**Round 2 anchors (narrowing):**
- Neural Sampling from Boltzmann Densities (6.40): Already discussed above. CMT stronger.
- LiFlow (6.33): Flow matching for atomic transport, different problem.
- Training-free Guidance (6.25): Flow matching guidance, different problem.
- BoPITO / pRCOZllZdT (7.00): Boltzmann priors for transfer operators. CMT has more comprehensive empirical evaluation (4 systems vs. 2, competitive baselines vs. single baseline). CMT is slightly stronger but comparable in quality.
- GeoBFN (8.00): Already discussed. Different domain, highly polished.
- Force-Guided Bridge Matching (7.00): MD time-coarsened dynamics, different problem.
- GFlowNets (7.33): Discrete/structured distributions, strong theory + evaluation but different domain.

**Final score determination:** CMT is stronger than BoPITO (7.00) on empirical comprehensiveness and competitive baselines, but has a factual inaccuracy (Ram TV claim) and an oversold abstract that BoPITO does not. These are fixable narrative issues. Score: **7.0**.

MY FINAL SCORE: <score>7.0</score>
MY FINAL DECISION: <decision>Accept</decision>